Trademark: 79062177
Word
EXIQON SEEK FIND VERIFY
Status Date
Friday, February 26, 2021
Registration Number
3810965
Registration Date
Tuesday, June 29, 2010
Filing Date
Tuesday, October 28, 2008
Published for Opposition
Tuesday, April 13, 2010
Cancellation Date
Friday, February 26, 2021
1 Chemical products for diagnostic, industrial and scientific purposes, namely, industrial chemicals, catalysts for chemical and biochemical processes and chemicals used in the manufacture of pharmaceuticals and drug candidates, all of the aforementioned being for use in life science research, for use in the manufacture of anti-cancer drugs and drug candidates, and for use in in vitro diagnostics and in molecular and cancer diagnostics not for medical or veterinary purposes; Biochemical products for analyses of nucleic acids, nucleotides, oligonucleotides, DNA and RNA, namely, biochemical catalyst, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays not for medical or veterinary purposes, and molecular and cell-based oncology assays not for medical and veterinary purposes; Chemical reagents not for medical or veterinary purposes; Biochemical kits, consisting of biochemical preparations in the nature of biochemical catalysts, biochemical reagents commonly known as probes, and enzymes, for analysis of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA not for medical or veterinary purposes; Biochemical reagents, commonly known as probes for analyses of DNA, RNA, nucleotides, oligonucleotides, nucleic acids and for detecting RNA and microRNA not for medical or veterinary purposes
5 Chemical preparations for pharmaceutical, medical and veterinary use, namely, clinical medical reagents, diagnostic reagents, and assays for medical use; Chemico-pharmaceutical preparations, namely, biomedical preparations and assays for use in the detection of cancer in humans and animals and for use in oncology and pharmaceutical preparations for use in the prevention, treatment and cure of cancer; Chemical reagents for medical and veterinary purposes; Chemical preparations for medical therapeutic purposes, namely, preparations for the detection of cancer in humans and animals, for the treatment, prevention and cure of cancer, and for use in oncology; Diagnostic preparations for medical and veterinary purposes
42 Scientific research, development and consultancy relating thereto in the fields of chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; Biotechnological consultancy relating to DNA peptide and nucleotide syntheses
45 [ Licensing of intellectual property rights, including patent utilisation concerning chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; Consultancy services concerning the issuing of intellectual property rights licenses, and of licenses relating to the use of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA ]
The color(s) blue is/are claimed as a feature of the mark.
The mark consists of the wording "EXIQON" appearing above the words "Seek Find Verify" with all the aforementioned wording appearing in the color blue.
Jan 14, 2022
Total Invalidation Processed By The Ib
Dec 16, 2021
Total Invalidation Of Reg Ext Protection Sent To Ib
Dec 16, 2021
Invalidation Processed
Oct 26, 2021
Total Invalidation Of Reg Ext Protection Created
Apr 2, 2021
New Representative At Ib Received
Feb 26, 2021
Cancelled Section 71
Jan 6, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 6, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 29, 2019
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Apr 19, 2019
New Representative At Ib Received
Mar 15, 2019
Change Of Owner Received From Ib
Apr 12, 2018
International Registration Renewed
Jun 30, 2017
New Representative At Ib Received
Jun 23, 2017
Partial Invalidation Processed By The Ib
Mar 2, 2017
Generic Madrid Transaction Sent To Ib
Mar 2, 2017
Generic Madrid Transaction Created
Dec 27, 2016
Partial Invalidation Of Reg Ext Protection Created
Apr 27, 2016
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Apr 27, 2016
Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.
Apr 27, 2016
Case Assigned To Post Registration Paralegal
Mar 4, 2016
Teas Section 71 & 15 Received
Nov 27, 2015
New Representative At Ib Received
Feb 11, 2013
Final Decision Transaction Processed By Ib
Oct 6, 2010
Final Disposition Notice Sent To Ib
Oct 6, 2010
Final Disposition Processed
Sep 29, 2010
Final Disposition Notice Created, To Be Sent To Ib
Jun 29, 2010
Registered-Principal Register
Jun 4, 2010
Notification Of Possible Opposition - Processed By Ib
May 14, 2010
Notification Of Possible Opposition Sent To Ib
May 13, 2010
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 13, 2010
Official Gazette Publication Confirmation E-Mailed
Apr 13, 2010
Published For Opposition
Mar 10, 2010
Law Office Publication Review Completed
Mar 10, 2010
Approved For Pub - Principal Register
Mar 10, 2010
Examiner's Amendment Entered
Mar 10, 2010
Notification Of Examiners Amendment E-Mailed
Mar 10, 2010
Examiners Amendment E-Mailed
Mar 10, 2010
Examiners Amendment -Written
Feb 25, 2010
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 25, 2010
Assigned To Lie
Feb 24, 2010
Teas Voluntary Amendment Received
Oct 8, 2009
Final Refusal Mailed
Oct 7, 2009
Final Refusal Written
Aug 25, 2009
Teas/Email Correspondence Entered
Aug 25, 2009
Correspondence Received In Law Office
Aug 25, 2009
Assigned To Lie
Aug 10, 2009
Teas Response To Office Action Received
Mar 6, 2009
Refusal Processed By Ib
Feb 10, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Feb 10, 2009
Refusal Processed By Mpu
Feb 10, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Feb 9, 2009
Non-Final Action Written
Jan 29, 2009
Assigned To Examiner
Dec 19, 2008
Application Filing Receipt Mailed
Dec 18, 2008
Change Of Name/Address Rec'd From Ib
Dec 15, 2008
New Application Entered In Tram
Dec 12, 2008
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
